Service update: On February 16, 2025, LifeLabs employees represented by BCGEU provided Notice of Strike. Some of our Patient Service Centre locations will be temporarily closed beginning on Thursday, February 20, 2025. As an essential service, LifeLabs will remain operational; however, there may be general delays. Before visiting a Patient Service Centre, please check our location finder for the latest information. Customers with appointments will be notified if rescheduling is required. We apologize for any inconvenience and thank you for your patience.
Featured News by Tag: Cancer
Featured News
February
1
2023
LifeLabs launches Signatera, offering Canadians an innovative and personalized approach to managing cancer
February 1, 2023. – Toronto, ON: LifeLabs is pleased to share the launch of SignateraTM, a highly sensitive, personalized molecular residual disease assay (MRD) test developed by Natera for treatmen...
December
15
2022
LifeLabs forms new collaboration with Natera to offer molecular residual disease (MRD) testing for cancer in Canada
LifeLabs is pleased to announce its new collaboration with Natera, Inc., (NASDAQ: NTRA), a global leader in cell-free DNA testing, to offer* personalized testing for cancer in Canada through Natera’...